FMD Advice Notice
Please see the following FMD Advice notice from NHS England, published 7th February 2019.
The Falsified Medicines Directive (FMD) will apply from tomorrow, 9th February 2019, please make sure understand what is expected of you and are working towards compliance.
Please read the following letter in full and see the links below for further support
Who’s responsible for FMD? |RPS
In preparation for FMD compliance, please read the following article from the Royal Pharmacietical Society.
NHS Long Term Plan
This is the most easy read version of the most important document that is going to affect our working lives.
The NHS Long Term Plan was developed in partnership with those who know the NHS best – frontline health and care staff, patients and their families and other experts.
The development of Primary Care Networks will seriously affect the way we work and the concept requires some thought and understanding to optimise your chances of joint working with newly configured MDTs.
Foundation Pharmacist Role Analysis | Royal Pharmaceutical Society
Please see the following message from RPS, give your opinion support by completing the short questionnaire.
Foundation Pharmacist Role Analysis
Shape the future training and development of foundation pharmacists across the UK!
The Royal Pharmaceutical Society and Health Education England are analysing the roles of pharmacists in the early years of their careers. RPS will use the analysis to guide the design and review of a UK wide Foundation Pharmacist Framework. The framework will test skills and capabilities at the point of entry, during development and upon completion of training programmes.
HEE will use the analysis to inform the pharmacy education and training review which is currently underway.
In the first phase of the role analysis, we gathered a broad spectrum of views and evidence. We are now seeking wider feedback on the identified criteria for the core skills, knowledge and behaviours included in the draft framework.
We greatly value your input and contribution into this important work.
The questionnaire https://www.surveymonkey.co.uk/r/FoundationPharmacistSurvey
will be available for completion until
Thursday 28th February 2019 and will take approximately 20 minutes
Information you provide will remain anonymous and your contribution will be kept confidential, with responses reported at the group level in final reports.
For help and comments please contact Emma-Louise Rowe on email@example.com
Drug costs and doctors
A document from BMJ Open states finds the following.
Doctors in dispensing practices are more likely to prescribe higher cost drugs. This is the largest study ever conducted on dispensing practices, and the first contemporary research suggesting some UK doctors respond to a financial conflict of interest in treatment decisions. The reimbursement system for dispensing practices may generate unintended consequences. Robust routine audit of practices prescribing higher volumes of unnecessarily expensive drugs may help reduce costs.
Reminder: National Campaign- Help us Help you
We hope you are all actively participating in the National Campaign launched Monday, Help us Help you- Before it gets worse.
Be reminded that this campaign is the first of the six national campaigns for 2019/2020 that all pharmacies MUST participate in as part of the CPCF.
You should have already received your resources from NHS England, please click here for more information on the campaign and further resources to support your participation.
If you have any queries or concerns, please contact the LPC office.
Reminder: Further vaccine ordering guidance for 2019/2020
Please be reminded that NHS England issued an update further to their ordering guidance letter for 2019/2020 that was published late last year.
Primary care immunisation update webinar series – a free training resource for immunisers in London | PHE
Free training resource for Immunisers in London from Public Health England, please see below the flyer with the dates and links to register.
2019 RPS/UCL School of Pharmacy New Year Lecture on the Treatment and Prevention of Diabetes | UCL
Polypharmacy: Getting our medicines right | RPS
Obesity-related cancers rise for younger US generations, study says | BBC
Class 4 Drug Alert: Amoxicillin 500mg Capsules BP (MDR 92-12/18)
A change to the Patient Information Leaflet (PIL) for this product has not been implemented by the required timeline. The change concerns the addition of the symptoms of a potential side effect, ‘Drug Reaction with Eosinophilia and Systemic Symptoms’ (DRESS).
Please see the affected product details and a brief description of what is required below. Ensure you read the full alert before taking action.
Accord Healthcare Limited
Amoxicillin 500mg Capsules
Batch number Expiry date Pack size First distributed
MP 18062 01/ 2021 1 x 21 04 Oct 2018
MP 18063 01/ 2021 1x 1 x 21 26 Oct 2018
MP 18064 01/ 2021 1x 1 x 21 16 Oct 2018
Advice for healthcare professionals
When dispensing this product, please check the Marketing Authorisation Holder and the batch number. If any of the above batch numbers are being dispensed, please remove the PIL in the pack and provide a copy of the correct version, which can be downloaded from the link below: